Fractyl Health (GUTS) announced on Friday that patients who stopped taking the GLP-1 class drug Tirzepatide and were treated ...

Dr. Eithan Haim has said publicly that he leaked the documents to a conservative activist in 2023 to “expose” care that he ...

Though the trial for patients with obesity and type 2 diabetes will come to an end, an obesity-only trial will continue.

Metsera, the firm Pfizer acquired, is modest yet ambitious. The primary medicine the company makes, MET-097i, is a once-monthly GLP-1 injection that has already demonstrated good early weight-loss ...

LONDON (Reuters) -AstraZeneca said on Friday it will sell its diabetes and asthma drugs direct to cash-paying U.S. patients ...

Novo Nordisk's Q2 2025 sales surge as Wegovy demand grows, driven by new obesity drug data. Click here to read an analysis of ...

US pharma major Eli Lilly has halted a study of an experimental drug, bimagrumab, designed to prevent obesity patients from ...

What is going on with the stock market? It just keeps rising. To understand where the markets are going and how they are ...

Viking Therapeutics targets obesity and MASH with high-risk prospects, trial concerns, and strong funding, but lags leaders ...

Tylenol maker Kenvue is reeling after unsupported claims that its popular drug causes autism. Kennedy is unlikely to stop ...

Tennis icon Serena Williams appeared irked by the decor choice of an unnamed New York City hotel after she spotted a cotton ...

Klotman took the helm at Baylor in 2010 after holding leadership roles at Mt. Sinai School of Medicine, the National ...